163 related articles for article (PubMed ID: 38774015)
21. Practical management of older adults with cancer: geriatric oncology in Japan.
Mizutani T
Jpn J Clin Oncol; 2022 Oct; 52(10):1073-1081. PubMed ID: 35863011
[TBL] [Abstract][Full Text] [Related]
22. Protocol for a randomised controlled trial on impact of comprehensive geriatric and supportive assessment versus standard care in older adults with cancer undergoing curative treatment: The Geriatric Oncology SuPportive clinic for ELderly (GOSPEL) study.
Goh WY; Neo HY; Teo HL; Koh MYH; Griva K; Lim MY; Ho FCH; Hum AYM
J Geriatr Oncol; 2023 Jan; 14(1):101342. PubMed ID: 35843845
[TBL] [Abstract][Full Text] [Related]
23. Impact of therapeutic management and geriatric evaluation on patient of eighty years and older with diffuse large B-cell lymphoma on survival: A systematic review.
Briand M; Gerard S; Gauthier M; Garric M; Steinmeyer Z; Balardy L
Eur J Haematol; 2022 Jan; 108(1):3-17. PubMed ID: 34496073
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of Older Adults with Non-Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis.
Wudhikarn K; Johnson BM; Inwards DJ; Porrata LF; Micallef IN; Ansell SM; Hogan WJ; Paludo J; Villasboas JC; Johnston PB
Transplant Cell Ther; 2023 Mar; 29(3):176.e1-176.e8. PubMed ID: 36563788
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Park S; Hong J; Hwang I; Ahn JY; Cho EY; Park J; Cho EK; Shin DB; Lee JH
J Geriatr Oncol; 2015 Nov; 6(6):470-8. PubMed ID: 26522808
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
Ancochea Á; Salar A; García-Pallarols F; Gimeno E; Fernández-Rodriguez C; Sánchez-González B
Med Clin (Barc); 2015 Jun; 144(12):544-7. PubMed ID: 25110180
[TBL] [Abstract][Full Text] [Related]
27. Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review.
Milunović V; Hude I; Rinčić G; Galušić D; Grubešić A; Martinović M; Popović N; Divošević S; Brčić K; Međugorac M; Kužat L; Strahija D; Mrđenović S; Mandac Smoljanović I; Radić-Krišto D; Gašparov S; Aurer I; Ostojić Kolonić S
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428485
[TBL] [Abstract][Full Text] [Related]
28. [Risk of heart failure in patients with Hodgkin lymphoma after radiation and anthracycline chemotherapy].
Kriz J; Eich HT
Strahlenther Onkol; 2017 Aug; 193(8):677-678. PubMed ID: 28656374
[No Abstract] [Full Text] [Related]
29. High dose chemotherapy and autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: Emerging questions, newer agents, and changing paradigm.
Akhtar S
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):272-276. PubMed ID: 28641095
[TBL] [Abstract][Full Text] [Related]
30. On the aetiology of Hodgkin lymphoma.
Hjalgrim H
Dan Med J; 2012 Jul; 59(7):B4485. PubMed ID: 22759852
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Geriatric Assessment (CGA): A Simple Tool for Guiding the Treatment of Older Adults with Diffuse Large B-Cell Lymphoma in China.
Bai JF; Han HX; Feng R; Li JT; Wang T; Zhang CL; Liu H
Oncologist; 2020 Aug; 25(8):e1202-e1208. PubMed ID: 32436258
[TBL] [Abstract][Full Text] [Related]
32. Brentuximab vedotin plus nivolumab as first-line therapy in older or chemotherapy-ineligible patients with Hodgkin lymphoma (ACCRU): a multicentre, single-arm, phase 2 trial.
Cheson BD; Bartlett NL; LaPlant B; Lee HJ; Advani RJ; Christian B; Diefenbach CS; Feldman TA; Ansell SM
Lancet Haematol; 2020 Nov; 7(11):e808-e815. PubMed ID: 33010817
[TBL] [Abstract][Full Text] [Related]
33. Non-Hodgkin's lymphoma in the elderly. A review with emphasis on elderly patients, geriatric assessment, and future perspectives.
Maartense E; Kluin-Nelemans HC; Noordijk EM
Ann Hematol; 2003 Nov; 82(11):661-70. PubMed ID: 12923662
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes, Treatment Toxicity, and Health Care Utilization in Older Adults with Aggressive Non-Hodgkin Lymphoma.
Johnson PC; Yi A; Horick N; Amonoo HL; Newcomb RA; Lavoie MW; Rice J; Reynolds MJ; Ritchie CS; Nipp RD; El-Jawahri A
Oncologist; 2021 Nov; 26(11):965-973. PubMed ID: 34327767
[TBL] [Abstract][Full Text] [Related]
35. Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper.
Aapro M; Bernard-Marty C; Brain EG; Batist G; Erdkamp F; Krzemieniecki K; Leonard R; Lluch A; Monfardini S; Ryberg M; Soubeyran P; Wedding U
Ann Oncol; 2011 Feb; 22(2):257-67. PubMed ID: 20956616
[TBL] [Abstract][Full Text] [Related]
36. How old is too old? Frailty and geriatric assessments of older patients undergoing allogeneic HCT.
Jayani RV
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):709-714. PubMed ID: 38066893
[TBL] [Abstract][Full Text] [Related]
37. Older adults and the unique role of the radiation therapist: Future directions for improving geriatric oncology training and education.
Morris L; O'Donovan A; Hashmi A; Agar M
Tech Innov Patient Support Radiat Oncol; 2022 Sep; 23():21-26. PubMed ID: 36059564
[TBL] [Abstract][Full Text] [Related]
38. Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches.
Allen P
Curr Oncol Rep; 2020 Aug; 22(11):114. PubMed ID: 32827063
[TBL] [Abstract][Full Text] [Related]
39. Hodgkin lymphoma treatment for older persons in the modern era.
Evens AM; McKenna M; Ryu Tiger YK; Upshaw JN
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):483-499. PubMed ID: 38066840
[TBL] [Abstract][Full Text] [Related]
40. Ambulatory Medical Assistance--After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy.
Compaci G; Rueter M; Lamy S; Oberic L; Recher C; Lapeyre-Mestre M; Laurent G; Despas F
BMC Cancer; 2015 Oct; 15():781. PubMed ID: 26498342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
